Caspofungin: first approved agent in a new class of antifungals
Publication
, Journal Article
Johnson, MD; Perfect, JR
Published in: Expert Opinion on Pharmacotherapy
2003
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Expert Opinion on Pharmacotherapy
DOI
ISSN
1465-6566
Publication Date
2003
Volume
4
Issue
5
Start / End Page
807 / 823
Publisher
Informa UK Limited
Related Subject Headings
- Pharmacology & Pharmacy
- 3214 Pharmacology and pharmaceutical sciences
- 1115 Pharmacology and Pharmaceutical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Johnson, M. D., & Perfect, J. R. (2003). Caspofungin: first approved agent in a new class of antifungals. Expert Opinion on Pharmacotherapy, 4(5), 807–823. https://doi.org/10.1517/eoph.4.5.807.22216
Johnson, Melissa D., and John R. Perfect. “Caspofungin: first approved agent in a new class of antifungals.” Expert Opinion on Pharmacotherapy 4, no. 5 (2003): 807–23. https://doi.org/10.1517/eoph.4.5.807.22216.
Johnson MD, Perfect JR. Caspofungin: first approved agent in a new class of antifungals. Expert Opinion on Pharmacotherapy. 2003;4(5):807–23.
Johnson, Melissa D., and John R. Perfect. “Caspofungin: first approved agent in a new class of antifungals.” Expert Opinion on Pharmacotherapy, vol. 4, no. 5, Informa UK Limited, 2003, pp. 807–23. Crossref, doi:10.1517/eoph.4.5.807.22216.
Johnson MD, Perfect JR. Caspofungin: first approved agent in a new class of antifungals. Expert Opinion on Pharmacotherapy. Informa UK Limited; 2003;4(5):807–823.
Published In
Expert Opinion on Pharmacotherapy
DOI
ISSN
1465-6566
Publication Date
2003
Volume
4
Issue
5
Start / End Page
807 / 823
Publisher
Informa UK Limited
Related Subject Headings
- Pharmacology & Pharmacy
- 3214 Pharmacology and pharmaceutical sciences
- 1115 Pharmacology and Pharmaceutical Sciences